Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation

[1]  Annette S. Kim,et al.  Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models. , 2021, Cell reports.

[2]  Christopher A. Miller,et al.  Bam-readcount - rapid generation of basepair-resolution sequence metrics , 2021, J. Open Source Softw..

[3]  D. Shaw,et al.  Exploiting allosteric properties of RAF and MEK inhibitors to target therapy-resistant tumors driven by oncogenic BRAF signaling. , 2021, Cancer discovery.

[4]  Andrew Roth,et al.  PyClone-VI: scalable inference of clonal population structures using whole genome data , 2020, BMC Bioinformatics.

[5]  J. Kirkwood,et al.  Clinical Development of BRAF plus MEK Inhibitor Combinations. , 2020, Trends in cancer.

[6]  D. Schadendorf,et al.  Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors , 2019, JAMA network open.

[7]  S. Okabe,et al.  Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferation , 2018, Annals of Hematology.

[8]  Giulio Caravagna,et al.  Detecting repeated cancer evolution from multi-region tumor sequencing data , 2018, Nature Methods.

[9]  Christopher T. Saunders,et al.  Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.

[10]  Vladimir Vacic,et al.  Genome-wide somatic variant calling using localized colored de Bruijn graphs , 2018, Communications Biology.

[11]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[12]  Shaji K. Kumar,et al.  PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promise , 2018, Leukemia & lymphoma.

[13]  P. Poulikakos,et al.  New perspectives for targeting RAF kinase in human cancer , 2017, Nature Reviews Cancer.

[14]  Karen E Crowell,et al.  Cardiovascular Effects of the MEK Inhibitor, Trametinib: A Case Report, Literature Review, and Consideration of Mechanism , 2017, Cardiovascular Toxicology.

[15]  H. Goldschmidt,et al.  Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation , 2017, Oncogenesis.

[16]  V. Seshan,et al.  FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing , 2016, Nucleic acids research.

[17]  P. Poulikakos,et al.  Targeting RAS–ERK signalling in cancer: promises and challenges , 2014, Nature Reviews Drug Discovery.

[18]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[19]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[20]  S. Chandarlapaty,et al.  Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas. , 2012, Cancer cell.

[21]  Sarat Chandarlapaty,et al.  Negative feedback and adaptive resistance to the targeted therapy of cancer. , 2012, Cancer discovery.

[22]  Mari Mino-Kenudson,et al.  EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. , 2012, Cancer discovery.

[23]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[24]  C. Sander,et al.  V600EBRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway , 2009, Proceedings of the National Academy of Sciences.

[25]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[26]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..

[27]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[28]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .